Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Can-Fite BioPharma Ltd. announces the exercise of warrants for approximately $4.0 million in gross proceeds. The company plans to use the funds for research, development, and clinical trials.

PUBLIC · CANFSep 02, 2026•3 days ago

Amount Raised

$4 Million

Round Type

Seed

IsraelHealthcare

Description

Can-Fite BioPharma Ltd. has announced the immediate exercise of outstanding warrants generating approximately $4.0 million in gross proceeds. These funds will be used to support research and development efforts as well as clinical trials. The closing of the offering is expected to occur shortly

Company Information

Company

Can-Fite BioPharma Ltd.

Location

Israel

About

Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and

Don't miss Can-Fite BioPharma Ltd.'s next move

Get an email the moment Can-Fite BioPharma Ltd. raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Can-Fite BioPharma Ltd.'s next move

See what Strategic adds

Can-Fite BioPharma Ltd. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.